Eydelman Mikhail 4
4 · Vaxcyte, Inc. · Filed Mar 3, 2025
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Eydelman Mikhail
SVP, GEN COUNSEL & CORP SEC
Transactions
- Tax Payment
Common Stock
2025-02-28$73.02/sh−470$34,319→ 42,236 total - Tax Payment
Common Stock
2025-03-03$72.10/sh−616$44,414→ 41,620 total - Award
Stock Option (right to buy)
2025-02-27+48,357→ 48,357 totalExercise: $74.22Exp: 2035-02-26→ Common Stock (48,357 underlying) - Award
Common Stock
2025-02-27+14,484→ 42,706 total
Footnotes (3)
- [F1]Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 7, 2025 and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.
- [F2]Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
- [F3]1/48 of shares subject to the option vest on March 27, 2025, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.